Navigation Links
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Date:8/3/2009

Wu was vice president of business development at Genelabs Technologies Inc., where he was responsible for all business development and licensing activities, including search, evaluation, contract negotiations for all in- and out-license transactions as well as alliance management and assisting in corporate financing activities. At Genelabs, Wu completed numerous licensing agreements and research collaborations with companies including Novartis, Gilead and Affymetrix.

Prior to Genelabs, Wu participated in the 1997 establishment of Kissei Pharma, the U.S. subsidiary of Kissei Pharmaceuticals Co. of Japan. Wu also was director of business development for Quintiles-BRI, a clinical research organization, after working for 16 years at Syntex Corporation. At Syntex, he held numerous positions with increasing responsibility, beginning as a chemist at the Syntex Research Institute of Pharmaceutical Sciences and culminating as director of R&D Program Planning and Management for the company's Japanese subsidiary.

Wu received his MBA in International Finance from the University of San Francisco, School of Business. He has been a member of the American Association of Pharmaceutical Scientist Planning Committee for Harmonization of Pharmaceutical Science Requirements, the New York Pharma Forum, the Japan Society of Northern California, the Healthcare Study Group (JETRO New York), the Regulatory Affairs Professional Society, and the Licensing Executive Society and Drug Information Association. Wu has been a frequent speaker at conferences including the Bay Bio Panel, Hepatitis C in Search of a Cure, Conducting Clinical Trials in Japan, Pacific Rim Biotech Conference and BIO.

About NovaBay

NovaBay Pharmaceuticals is a mid-stage biopharmaceutical company focused on developing its proprietary and patented Aganocide(R) compounds, which are novel, synthetic anti-infective product candidates that are
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
2. OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
3. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
4. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
5. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
6. Brookstone Pharmaceuticals Appoints New Corporate Position
7. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
8. Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
9. Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
10. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
11. BioCryst Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... , May 20, 2013   BioHealth ... focusing on commercializing market-relevant biohealth innovations and increasing ... Maryland , today announced its selection of ... (EIR) for BHI at the National Institutes of ... Institute (NHLBI). Dr. Aiyar will help advance ...
(Date:5/20/2013)... Researchers from the Southern University of Denmark ... and the acne causing P.acnes bacteria. Researchers believe found that ... out oxygen deprived location to seek shelter and grow. When ... the ability to live in the open joint areas, causing ... “ The best acne treatment ” explains why starting a ...
(Date:5/20/2013)... 2013 The World Molecular Imaging Society ... Lisa Baird as Executive Director. Baird will assume ... The WMIS vision is to encompass and promote ... effectively treat diseases in the developed and developing world. ... in 2011 by integrating the Academy of Molecular Imaging ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2
... /PRNewswire-FirstCall/ Varian, Inc. (NasdaqGS:,VARI) announced that its Board ... new director. Glover is the seventh member of ... a term expiring at the annual meeting of,the ... Vice President, Operations and Chief Financial Officer,of Anadys ...
... May 7 Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) ... 31, 2008., Total revenues in the first quarter ... the first quarter of 2007, and included $2.0 million ... $0.6 million in patent reimbursements from Arena,s collaborations with,Merck ...
... to Provide Full Functional Validation Data for Its MISSION(R) ... ... LOUIS, May 7 Sigma-Aldrich(TM) (Nasdaq:,SIAL) and the second phase ... Consortium,s collection of approximately,160,000 previously-cloned lentiviral-based shRNA vector constructs.,Currently, more ...
Cached Biology Technology:James T. Glover Appointed to Board of Directors of Varian, Inc. 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 8Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 2Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 3
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... Scientists investigating the interaction of a group of proteins ... damage have identified a new target that could increase ... the University,s School of Biochemistry and published in the ... Reviews, could eventually lead to new therapies for stroke ... earlier work by the team which identified a protein, ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2
... Spring Harbor, NY A team of neuroscientists at Cold ... to a GPS system for locating and tracking a vital ... identification, particularly in living animals. The cells ... neurotransmitter called GABA (gamma aminobutyric acid). GABA neurons function ...
... mussels, squids as different as they may look, ... to the phylum Mollusca , also called molluscs. ... and Professor Ken Halanych, USA, with the participation of ... research into the relationships among different molluscs as part ...
... to make pest insects buzz off for good or even ... a tiny finding with enormous potential. Sujata Chaudhari, a ... the senior author of a study that was published this ... Sciences , also called PNAS. Her work includes a discovery ...
Cached Biology News:Team creates genetic 'GPS' system to comprehensively locate and track inhibitory nerve cells 2Team creates genetic 'GPS' system to comprehensively locate and track inhibitory nerve cells 3Team creates genetic 'GPS' system to comprehensively locate and track inhibitory nerve cells 4Research into molluscan phylogeny reveals deep animal relationship of snails and mussels 2Research into molluscan phylogeny reveals deep animal relationship of snails and mussels 3From protein to planes and pigskin 2From protein to planes and pigskin 3
Automated Cell Culture Flask...
Cell Culture Flask, 75 cm, treated polystyrene...
... style shaker flasks have three extra deep ... solutions to improve oxygen or gas transfer ... The long neck reduces splashing and is ... wall thickness provides the proper balance between ...
... 100 IS System is a compact analysis system ... lasers, optics, fluidics, a controller, advanced digital signal ... compact lab analysis system includes the Luminex 100, ... has a DMF file at the FDA, and ...
Biology Products: